Orthofuse
A medtech startup developing 'tweakable' 3D-printed titanium implants that allow surgeons to perform intraoperative customization for spinal and orthopedic procedures.
- CEO / Founder
- James Scott
- Team Size
- 1-10
- Stage
- Seed stage; recently raised £2.2M (Feb 2024) to advance technical development, regulatory readiness, and early-stage clinical evaluations.
- Total Funding
- £2.2M
- Latest Round
- Seed
- Key Investors
- ["ACF Investors","Cambridge Angels","Empirical Ventures"]
Technology & Products
Key Products
["Adjustable 3D-printed titanium spinal cages","Intraoperative surgical adjustment tools","Proprietary lattice-structured orthopedic implants","Surgical workflow integration systems"]
Technological Advantage
Combines the precision of additive manufacturing with mechanical adjustability, bridging the gap between generic off-the-shelf implants and expensive, slow-to-produce patient-specific custom devices.
Market & Competition
Target Customers
Spinal and orthopedic surgeons, hospitals, and specialized surgical centers.
Industry Verticals
["Medical Devices","Orthopedics","Spinal Surgery","Additive Manufacturing (3D Printing)"]
Competitors
["4WEB Medical","Carlsmed","Medtronic (Medicrea)"]